B
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A70.4 KBBioverativ Inc.Apr 10, 11:15 AM ET·0001104659-18-023188
- 8-K170.0 KBBioverativ Inc.Mar 8, 9:28 AM ET·0001104659-18-015757
- 10-K/A1.1 MBBioverativ Inc.Mar 8, 9:08 AM ET·0001558370-18-001682
- SC 13G/A70.3 KBBioverativ Inc.Feb 27, 6:06 AM ET·0001104659-18-012374
- SC 13G/A152.3 KBBioverativ Inc.Feb 14, 1:41 PM ET·0001144204-18-008643
- 10-K11.1 MBBioverativ Inc.Feb 14, 7:57 AM ET·0001558370-18-000672
- 8-K1.1 MBBioverativ Inc.Feb 13, 4:30 PM ET·0001558370-18-000636
- SC 13G45.1 KBBioverativ Inc.Feb 8, 11:52 AM ET·0000932471-18-002711
- 8-K174.7 KBBioverativ Inc.Feb 6, 5:13 PM ET·0001681689-18-000003
- 8-K899.4 KBBioverativ Inc.Jan 22, 8:20 AM ET·0001104659-18-003187
Insiders
10- BIOGEN INC.10% Owner
- Brudnick RichardEVP, Business Development
- Celona LuciaEVP, HR & Corp Commun. Officer
- Cox JohnDirector, Chief Executive Officer
- DENNER ALEXANDER JDirector
- DiFabio AndreaEVP, Chief Legal Officer
- Duvall DianthaChief Accounting Officer
- Germano Geno JDirector
- Greene JohnEVP, CFO and Treasurer
- Harris Timothy J.R.EVP, R & D
Tickers
No tickers on record
Addresses
business
225 2ND AVENUE
WALTHAM, MA, 02451
mailing
225 2ND AVENUE
WALTHAM, MA, 02451